Evidence map›Paper›PMID 12006325›Full record

Trial reportAnnals of the rheumatic diseases2002

Neutrophil CD64 expression: distinguishing acute inflammatory autoimmune disease from systemic infections.

E Allen, A C Bakke, M Z Purtzer, A Deodhar

Open access · bronzeAbstract readClinical TrialControlled Clinical Trial
In one paragraph

Trial report in Annals of the rheumatic diseases, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Myeloid and lymphoid expression ofScience translational medicine · 2024
    Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Review
  12. Article
  13. CD35 and CD64 of Neutrophils Can Differentiate Between Bacterial and Viral Infections in Children by Simultaneous Quantitative Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

E AllenDivision of Arthritis and Rheumatic Diseases - OP09, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97201, USA.
A C Bakke
M Z Purtzer
A Deodhar
Oregon Health & Science University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCommon bacterial and opportunistic infections are a major cause of mortality in patients who are immunosuppressed owing to treatment with corticosteroids or cytotoxic drugs. Common laboratory tests for infection lack sensitivity and specificity. One of the new generation of tests to detect early systemic infections measures the up regulation of an Fc receptor (Fcgamma R1, or CD64) on neutrophils. The Fc receptors on white blood cells are very important for effective phagocytosis of bacteria and are up regulated during an infection.

objectiveTo measure the clinical usefulness of quantitative CD64 measurements to differentiate between systemic infection and active autoimmune inflammation in an ongoing study.

methodsPatients with systemic infection (n=27), active autoimmune inflammatory disease (n=44), vasculitis (n=5), and controls (n=20) were studied for neutrophil CD64 expression using monoclonal antibodies and flow cytometry.

resultsThe median (interquartile range (IQR)) CD64 expression in patients with active inflammatory disease and systemic infection was 907.5 (586-1550) and 3647 (2380-6642), respectively (p<0.0001). The median (IQR) CD64 expression in control patients (osteoarthritis and fibromyalgia) was 505 (359-599). The sensitivity and specificity of CD64 expression on neutrophils to diagnose systemic infection (using a cut off value of 2000) was 85% and 91%, respectively.

conclusionThese results indicate that quantitative measurement of CD64 can distinguish between systemic infection and the flare of autoimmune diseases.

Indexed as

Acute-Phase ReactionAdolescentAdultAgedAntirheumatic AgentsAutoimmune DiseasesBiomarkersDiagnosis, DifferentialFemaleFlow CytometryHumansImmunosuppressive AgentsInfectionsMaleMiddle AgedNeutrophilsAntirheumatic AgentsBiomarkersImmunosuppressive AgentsReceptors, IgG

Identifiers

PMID12006325
PMCPMC1754114
OpenAlexW2156392205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.